K
Karen G. Hirsch
Researcher at Stanford University
Publications - 52
Citations - 2215
Karen G. Hirsch is an academic researcher from Stanford University. The author has contributed to research in topics: Cardiopulmonary resuscitation & Medicine. The author has an hindex of 17, co-authored 43 publications receiving 1174 citations. Previous affiliations of Karen G. Hirsch include Virginia Commonwealth University & Johns Hopkins University School of Medicine.
Papers
More filters
Journal ArticleDOI
Part 4: Pediatric Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
Ashish R. Panchal,Jason A. Bartos,Jose G. Cabanas,Michael W. Donnino,Ian R. Drennan,Karen G. Hirsch,Peter J. Kudenchuk,Michael C. Kurz,Eric J. Lavonas,Peter T. Morley,Brian J. O'Neil,Mary Ann Peberdy,Jon C. Rittenberger,Amber J Rodriguez,Kelly N. Sawyer,Katherine Berg,Adult Basic +16 more
TL;DR: The Pediatric Basic and Advanced Life Support Collaborators aim to provide real-time information and guidance to parents and clinicians on how to care for their children during the neonatal intensive care unit and beyond.
Journal ArticleDOI
Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients.
Aaron M. Cook,G. Morgan Jones,Gregory W.J. Hawryluk,Patrick Mailloux,Diane McLaughlin,Alexander Papangelou,Sophie Samuel,Sheri Tokumaru,Chitra Venkatasubramanian,Christopher Zacko,Lara Zimmermann,Karen G. Hirsch,Lori Shutter +12 more
TL;DR: The available evidence suggests hyperosmolar therapy may be helpful in reducing ICP elevations or cerebral edema in patients with SAH, TBI, AIS, ICH, and HE, although neurological outcomes do not appear to be affected.
Journal ArticleDOI
2019 American Heart Association Focused Update on Advanced Cardiovascular Life Support: Use of Advanced Airways, Vasopressors, and Extracorporeal Cardiopulmonary Resuscitation During Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
Ashish R. Panchal,Katherine Berg,Karen G. Hirsch,Peter J. Kudenchuk,Marina Del Rios,Jose G. Cabanas,Mark S. Link,Michael C. Kurz,Paul S. Chan,Peter T. Morley,Mary Fran Hazinski,Michael W. Donnino +11 more
TL;DR: This 2019 focused update to the American Heart Association advanced cardiovascular life support guidelines summarizes the most recent published evidence for and recommendations on the use of advanced airways, vasopressors, and extracorporeal cardiopulmonary resuscitation during cardiac arrest.
Journal ArticleDOI
2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
Ashish R. Panchal,Katherine Berg,Peter J. Kudenchuk,Marina Del Rios,Karen G. Hirsch,Mark S. Link,Michael C. Kurz,Paul S. Chan,Jose G. Cabanas,Peter T. Morley,Mary Fran Hazinski,Michael W. Donnino +11 more
TL;DR: This article includes the revised recommendation that providers may consider either amiodarone or lidocaine to treat shock-refractory ventricular fibrillation/pulseless ventricular tachycardia cardiac arrest.
Journal ArticleDOI
Inhibition of PI-3 kinase sensitizes human leukemic cells to histone deacetylase inhibitor-mediated apoptosis through p44/42 MAP kinase inactivation and abrogation of p21 CIP1/WAF1 induction rather than AKT inhibition
TL;DR: Findings indicate that LY promotes SB-mediated apoptosis through an AKT-independent process that involves MEK/MAP kinase inactivation and interference with p21CIP1/WAF1 induction.